Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Clinicaltrials.gov ID: NCT07231159
db-list-check Status RECRUITING
b-loader Phase
b-people Age ≥ 18 Years
b-bullseye-arrow Enrollments 200

Conditions

Breast Cancer, Lung Cancer (Diagnosis), Prostate Cancer

Summary

To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

Locations

1 location Found with status Recruiting

Status

  • RECRUITING

Central Contacts

Principal Investigator

  • Mark Socinski, MD

Eligibility Criteria

Inclusion Criteria:

1. Adult aged 18 or older
2. Seeking care at a CRS or emergency department
3. Meets criteria for lung, breast, and/or prostate cancer screening, as outlined below:

1. Lung cancer: Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
2. Breast cancer: Women aged 40 to 74 years
3. Prostate cancer: Men aged 55 to 69 years
4. Receives a positive screening result for lung, breast, and/or prostate cancer at a study site

Exclusion Criteria:

1. Displays behavior disruptive to other patients or staff
2. Refusal to accept screening for breast, lung, and/or prostate cancers

Study Plan

community-based initiative for screening, diagnosis, and treatment of breast, lung, and prostate

Identify differences between adults who accept or decline cancer follow-up diagnosis and treatment, and clinical trial screening Identify barriers and facilitators to cancer screening, diagnosis, treatment, and clinical trial screening Understand perceptions towards navigators in the cancer care continuum

  • BEHAVIORAL:

    referral for definitive diagnosis based on their cancer screening results

    Description:

    Need for radiological diagnosis

Recruitment of Stakeholder

Investigators will establish relationships with community stakeholders, providers, and other key personnel to inform them of the program, the study, and opportunities to engage in stakeholder focus groups to provide feedback about program operations. For those interested in participating, a study team member will explain the study and the requirements for participation, review the informed consent form in detail, and obtain consent.

  • BEHAVIORAL:

    Engagement

    Description:

    Engage in stakeholder focus groups to provide feedback about program operations

Outcome Measures

Primary Outcome Measures

The categorization of the RE-AIM model dimensions of Reach, Effectiveness, Adoption, Implementation, and Maintenance,

Time Frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Secondary Outcome Measures

PROMIS Global Health (HR-QoL) scale

Time Frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Patient Satisfaction with Logistical Aspects of Navigation Scale (PSN-L)

Time Frame: From enrollment to the end of the 3 month follow-up for a total of 12 months

Timeline

  • Last Updated
    November 17, 2025
  • Start Date
    November 17, 2025
  • Today
    February 1, 2026
  • Completion Date ( Estimated )
    August 31, 2026

Similar Trials

light-list-check RECRUITING light-blue-people 18 - 80 Years
light-list-check RECRUITING light-blue-people 40 - 90 Years
light-list-check RECRUITING light-blue-people ≥ 18 Years